According to Fortune Business Insights, the global breast cancer therapeutics market was valued at USD 21.58 billion in 2019 and is projected to reach USD 55.27 billion by 2027, exhibiting a compound annual growth rate (CAGR) of 13.1% during the forecast period. In 2019, North America dominated the market with a 47.91% share.
